Compound 1938
Identifiers
- Canonical SMILES:
Oc1ccc(Br)cc1-c1cc(-c2ccccc2)c(C#N)c(=O)[nH]1
- IUPAC name:
6-(5-bromo-2-hydroxyphenyl)-2-oxo-4-phenyl-1,2-dihydropyridine-3-carbonitrile
- InChi:
InChI=1S/C18H11BrN2O2/c19-12-6-7-17(22)14(8-12)16-9-13(11-4-2-1-3-5-11)15(10-20)18(23)21-16/h1-9,22H,(H,21,23)
- InChiKey:
SVSYJTYGPLVUOZ-UHFFFAOYSA-N
External links
![]() 1235170 |
![]() CHEMBL391586 |
VRV |
DB08705 |
External search
![]() |
![]() |
![]() |
![]() |
![]() |
Bibliography (1)
Pharmacological data
Biochemical tests | Cellular tests | PK tests | Cytotoxicity tests |
---|---|---|---|
3 | 0 | 0 | 0 |
Targets
PPI family | Best activity | Diseases | MMoA |
---|---|---|---|
Survivin dimer | 5.30 | cancer | Stabilization |
Physicochemical filters
Descriptor | Lipinski's RO5 | Veber | Pfizer's 3/75 | |
---|---|---|---|---|
Compliance | ||||
MW | 366.00 g/mol | |||
HBA | 4 | |||
HBD | 2 | |||
HBA + HBD | 6 | |||
AlogP | 3.11 | |||
TPSA | 70.32 | |||
RB | 2 |
Radar chart
PCA : iPPI-DB chemical space
PCA : Correlation circle
Efficiencies: iPPI-DB biplot LE versus LLE
Summary
Bibliographic ressources | Biochemical tests | Cellular tests | PK tests | Cytotoxicity tests |
---|---|---|---|---|
1 | 3 | 0 | 0 | 0 |
Pharmacological data
Bibliography | Name | Target | Competition | Assay type | Assay name | Cell line | Activity type | Activity |
---|---|---|---|---|---|---|---|---|
10.1016/j.bmcl.2007.03.042 | 1 | BIRC5 O15392 |
|
Biochemical assay | ASMS | pKd (dissociation constant, -log10) | 5.30 | |
10.1016/j.bmcl.2007.03.042 | 1 | BIRC5 O15392 |
|
Biochemical assay | NMR chemical-shift perturbation | pKd (dissociation constant, -log10) | 5.30 | |
10.1016/j.bmcl.2007.03.042 | 1 | BIRC5 O15392 |
|
Biochemical assay | Fluorescence Polarization | pKd (dissociation constant, -log10) | 5.24 |
Ta | Structure | Name | Drugbank ID |
---|---|---|---|
1.0000 | 6-(5-BROMO-2-HYDROXYPHENYL)-2-OXO-4-PHENYL-1,2-DIHYDROPYRIDINE-3-CARBONITRILE | DB08705 | |
0.5396 | Milrinone | DB00235 | |
0.5000 | CRA_9076 | DB04215 | |
0.4520 | Perampanel | DB08883 | |
0.4371 | CRA_9678 | DB04563 | |
0.4336 | CRA_8696 | DB03159 | |
0.4204 | 3-(5-{[4-(AMINOMETHYL)PIPERIDIN-1-YL]METHYL}-1H-INDOL-2-YL)-1H-INDAZOLE-6-CARBONITRILE | DB07075 | |
0.4194 | [5-(5-Amino-1H-pyrrolo[3,2-b]pyridin-2-yl)-6-hydroxy-3'-nitro-3-biphenylyl]acetic acid | DB08232 | |
0.4167 | 3-(5-{[4-(AMINOMETHYL)PIPERIDIN-1-YL]METHYL}-1H-INDOL-2-YL)QUINOLIN-2(1H)-ONE | DB07025 | |
0.4156 | 2-{2-hydroxy-[1,1'-biphenyl]-3-yl}-1H-1,3-benzodiazole-5-carboximidamide | DB01725 | |
0.4155 | 2-(2-Hydroxy-Phenyl)-1h-Indole-5-Carboxamidine | DB02463 | |
0.4121 | Voxelotor | DB14975 | |
0.4110 | 4-(3-Pyridin-2-Yl-1h-Pyrazol-4-Yl)Quinoline | DB03921 | |
0.4103 | [2'-HYDROXY-3'-(1H-PYRROLO[3,2-C]PYRIDIN-2-YL)-BIPHENYL-3-YLMETHYL]-UREA | DB07247 | |
0.4064 | 2,3-diphenyl-1H-indole-7-carboxylic acid | DB08709 |